Skip to main content

Table 3 Frequency of use of OAP and/or OAC in association with the cardiovascular risk factors

From: Oral anticoagulant and antiplatelet drugs used in prevention of cardiovascular events in elderly people in Poland

Risk factor

OAP or OAC

OAP

OAC

OAP and OAC

 

n (%)

n (%)

n (%)

n (%)

Pharmacologically treated hypertension

1480

1354

151

25

 

(50.32%)

(46.04%)

(5.13%)

(0.85%)

Previus myocardial infarct

375

350

35

10

 

(67.69%)

(63.18%)

(6.32%)

(1.81%)

Previous stroke

261

237

25

1

 

(61.27%)

(55.63%)

(5.87%)

(0.23%)

History of atrial fibrilation

498

396

117

15

 

(56.91%)

(45.26%)

(13.37%)

(1.71%)

Coronary heart disease (without myocardial infarct)

426

382

58

14

 

(61.21%)

(54.89%)

(8.33%)

(2.01%)

Congestive heart failure

341

290

61

10

 

(64.22%)

(54.61%)

(11.49%)

(1.88%)

Pharmacologically treated diabetes

471

432

43

4

 

(46.82%)

(42.94%)

(4.27%)

(0.40%)

Pharmacologically treated dyslipidaemia

795

726

86

17

 

(63.20%)

(57.71%)

(6.84%)

(1.35%)

Current smoker

132

123

10

1

 

(29.40%)

(27.39%)

(2.23%)

(0.22%)

Overweight/obesity

1278

1159

142

23

(BMI ≥ 25 kg/m2)

(38.30%)

(34.73%)

(4.26%)

(0.69%)

  1. Data presented as n (%).
  2. OAP - Oral antiplatelet drugs, OAC - Oral anticoagulant drugs.